QD-based diagnostic systems have successfully targeted a broad range of cancer biomarkers, including PSA [4,7,27,61,102], carcinoembryonic antigen (CEA) [7], BRCA-1 gene sequences [105], Fe3+ ions in tumor environments [106], and even whole cancer cells [101]. This evidence concerns the gene BRCA1 and cancer.